105 related articles for article (PubMed ID: 1989391)
1. Cleavage and purification of prokaryotically expressed HIV gag and env fusion proteins for detection of HIV antibodies in the ELISA.
Ellinger S; Mach M; Korn K; Jahn G
Virology; 1991 Feb; 180(2):811-3. PubMed ID: 1989391
[TBL] [Abstract][Full Text] [Related]
2. An ELISA-inhibition assay for antibody to human immunodeficiency virus core antigen (p24).
Povolotsky J; Gold JW; Darminin P; Chein N; Baron P; Armstrong D
J Virol Methods; 1990 Oct; 30(1):109-14. PubMed ID: 2128300
[TBL] [Abstract][Full Text] [Related]
3. Bacterial expression of the caprine arthritis-encephalitis virus gag and env proteins and their use in enzyme-linked immunosorbent assay.
Clavijo A; Thorsen J
Am J Vet Res; 1995 Jul; 56(7):841-8. PubMed ID: 7574148
[TBL] [Abstract][Full Text] [Related]
4. Comparison of recombinant human immunodeficiency virus gag precursor and gag/env fusion proteins and a synthetic env peptide as diagnostic reagents.
Shoeman RL; Young D; Pottathil R; Victor J; Conroy RR; Crowl RM; Coleman T; Heimer E; Lai CY; Ganguly K
Anal Biochem; 1987 Mar; 161(2):370-9. PubMed ID: 3495201
[TBL] [Abstract][Full Text] [Related]
5. Site-directed enzyme-linked immunosorbent assay with a synthetic simian immunodeficiency virus SIVmac peptide identifying antibodies against the HIV-2 transmembrane glycoprotein.
Norrby E; Chiodi F; Whalley A; Parks E; Nauclér A; Costa CM; Torstensson R; Biberfeld G
AIDS; 1989 Jan; 3(1):17-20. PubMed ID: 2469436
[TBL] [Abstract][Full Text] [Related]
6. [Study of the antigenic structure of human immunodeficiency virus using synthetic peptides].
Ivanov VS; Chikin LD; Suvorova ZK; Kozhich AT; Ivanov VT
Bioorg Khim; 1992 Jun; 18(6):784-93. PubMed ID: 1384509
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
[TBL] [Abstract][Full Text] [Related]
8. A serological screening assay of human immunodeficiency virus type 1 antibodies based on recombinant protein p24-gp41 as a fusion protein expressed in Escherichia coli.
Mahboudi F; Irina NA; Chevalier A; Ghadiri A; Adeli A; Amini-Bavil-Olyaee S; Barkhordari F; Farzamfar B; Alinejad M
J Biotechnol; 2006 Sep; 125(2):295-303. PubMed ID: 16647775
[TBL] [Abstract][Full Text] [Related]
9. Overexpression and purification of human immunodeficiency virus type 1 env derived epitopes in Escherichia coli.
Sohn MJ; Lee ME; Park HS; Nham SU; Lee YI
J Biotechnol; 1996 Mar; 45(3):211-6. PubMed ID: 8721306
[TBL] [Abstract][Full Text] [Related]
10. Reactivity of an HIV gag gene polypeptide expressed in E. coli with sera from AIDS patients and monoclonal antibodies to gag.
Marcus-Sekura CJ; Woerner AM; Klutch M; Quinnan GV
Biochim Biophys Acta; 1988 Feb; 949(2):213-23. PubMed ID: 2449245
[TBL] [Abstract][Full Text] [Related]
11. New sensitive and specific assay for human immunodeficiency virus antibodies using labeled recombinant fusion protein and time-resolved fluoroimmunoassay.
Siitari H; Turunen P; Schrimsher J; Nunn M
J Clin Microbiol; 1990 Sep; 28(9):2022-9. PubMed ID: 2121790
[TBL] [Abstract][Full Text] [Related]
12. Detection of antibodies to p24 and gp41 epitopes of HIV by ELISA using the recombinant core protein (p24) and envelope synthetic protein (gp41).
Filice G; Soldini L; Orsolini P; Razzini E; Chiapparoli L; Gulminetti R; Cattaneo E; Achilli G
Microbiologica; 1991 Jan; 14(1):1-7. PubMed ID: 1906127
[TBL] [Abstract][Full Text] [Related]
13. Rapid and simple purification of human immunodeficiency virus 1 epitope gp41.
Sohn MJ; Cho SH; Jang WH; Chong YH; Nham SU; Lee YI
J Virol Methods; 1993 Jan; 41(1):93-100. PubMed ID: 7679396
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides.
Filice G; Soldini L; Orsolini P; Razzini E; Gulminetti R; Campisi D; Chiapparoli L; Cattaneo E; Achilli G
Microbiologica; 1991 Jul; 14(3):185-94. PubMed ID: 1717811
[TBL] [Abstract][Full Text] [Related]
15. Analysis of human serum antibodies to human immunodeficiency virus (HIV) using recombinant ENV and GAG antigens.
Kenealy W; Reed D; Cybulski R; Tribe D; Taylor P; Stevens C; Matthews T; Petteway S
AIDS Res Hum Retroviruses; 1987; 3(1):95-105. PubMed ID: 3304356
[TBL] [Abstract][Full Text] [Related]
16. HIV experimental vaccines based on the iscom technology using envelope and GAG gene products.
Akerblom L; Nara P; Dunlop N; Putney S; Morein B
Biotechnol Ther; 1993; 4(3-4):145-61. PubMed ID: 8292967
[TBL] [Abstract][Full Text] [Related]
17. Chimeric gag-V3 virus-like particles of human immunodeficiency virus induce virus-neutralizing antibodies.
Luo L; Li Y; Cannon PM; Kim S; Kang CY
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10527-31. PubMed ID: 1438241
[TBL] [Abstract][Full Text] [Related]
18. Expression of an immunogenic region of HIV by a filamentous bacteriophage vector.
Tsunetsugu-Yokota Y; Tatsumi M; Robert V; Devaux C; Spire B; Chermann JC; Hirsch I
Gene; 1991 Mar; 99(2):261-5. PubMed ID: 1673667
[TBL] [Abstract][Full Text] [Related]
19. Reliable confirmation of antibodies to human immunodeficiency virus type 1 (HIV-1) with an enzyme-linked immunoassay using recombinant antigens derived from the HIV-1 gag, pol, and env genes.
Ng VL; Chiang CS; Debouck C; McGrath MS; Grove TH; Mills J
J Clin Microbiol; 1989 May; 27(5):977-82. PubMed ID: 2787334
[TBL] [Abstract][Full Text] [Related]
20. Cleavage of procaryotically expressed human immunodeficiency virus fusion proteins by factor Xa and application in western blot (immunoblot) assays.
Ellinger S; Glockshuber R; Jahn G; Plückthun A
J Clin Microbiol; 1989 May; 27(5):971-6. PubMed ID: 2501357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
